X0306 4 2020-05-15 false 0001603756 Axonics Modulation Technologies, Inc. AXNX 0001756438 Dearen Danny L. 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false See Remarks Common Stock 2020-05-15 4 M false 2722.00 1.32 A 59213.00 D Common Stock 2020-05-15 4 M false 27278.00 0.98 A 86491.00 D Common Stock 2020-05-15 4 S false 15000.00 35.0295 D 71491.00 D Common Stock 2020-05-15 4 S false 15000.00 35.2367 D 56491.00 D Common Stock 2020-05-18 4 M false 15000.00 1.32 A 71491.00 D Common Stock 2020-05-18 4 S false 15000.00 37.2561 D 56491.00 D Common Stock 2020-05-19 4 M false 15000.00 1.32 A 71491.00 D Common Stock 2020-05-19 4 S false 15000.00 40.0518 D 56491.00 D Stock Option (Right to Buy) 0.98 2020-05-15 4 M false 27278.00 0.00 D 2026-01-15 Common Stock 27278.00 0.00 D Stock Option (Right to Buy) 1.32 2020-05-15 4 M false 2722.00 0.00 D 2027-05-23 Common Stock 2722.00 36095.00 D Stock Option (Right to Buy) 1.32 2020-05-18 4 M false 15000.00 0.00 D 2027-05-23 Common Stock 15000.00 21095.00 D Stock Option (Right to Buy) 1.32 2020-05-19 4 M false 9778.00 0.00 D 2027-05-23 Common Stock 9778.00 11317.00 D Stock Option (Right to Buy) 1.32 2020-05-19 4 M false 5222.00 0.00 D 2027-07-05 Common Stock 5222.00 19318.00 D This sale was pursuant to a 10b5-1 plan adopted by the reporting person on March 23, 2020. This transaction was executed in multiple trades at prices ranging from $34.58 to $35.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $35.00to $35.455. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $37.00 to $37.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $40 to $40.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option vest over a period of four years. 34,346 of the shares subject to the option vested on January 15, 2016 and the remainder vest at a rate of 1/36th per month commencing on January 15, 2017 provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 23, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 23, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. President, Chief Financial Officer /s/ Danny L. Dearen 2020-05-19